2. Academic Validation
  3. Novel Compounds as 5-HT2A Agonists for Treating Mental Illness or CNS Disorders

Novel Compounds as 5-HT2A Agonists for Treating Mental Illness or CNS Disorders

  • ACS Med Chem Lett. 2025 Feb 11;16(3):377-378. doi: 10.1021/acsmedchemlett.5c00066.
Ram W Sabnis 1,  Anika R Sabnis 2
Affiliations

Affiliations

  • 1 Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
  • 2 Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States.
PMID: 40104807 DOI: 10.1021/acsmedchemlett.5c00066
Abstract

Provided herein are novel compounds as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating mental illness or CNS disorders and processes for preparing such compounds.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z